miR-106a Is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B and Associated with Enhanced Levels of Interleukin-8

This study aimed to investigate miR-106a expression in peripheral blood mononuclear cells (PBMCs) of chronic hepatitis B (CHB) patients and to analyze the function of miR-106a. miR-106a expression levels in PBMCs from 40 healthy controls and 56 CHB patients were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR). The luciferase activity assays were used to determine whether miR-106a binds to 3'UTR of IL-8. miR-106a mimics and inhibitors were transfected into healthy PBMCs. IL-8 mRNA and protein levels were detected and determined by qRT-PCR and ELISA, respectively. The qRT-PCR results suggested that the PBMC miR-106a levels were decreased in CHB patients. IL-8 was augmented in CHB patients and was inversely correlated with miR-106a levels. The luciferase activity assays indicated that IL-8 is a target of miR-106a. Exogenous expression of miR-106a could significantly repress IL-8 expression at both mRNA and protein levels in PBMCs, whereas miR-106a inhibitor had the opposite effects. This study suggested that miR-106a is downregulated in PBMCs of CHB patients and that miR-106a may play an important role in CHB by targeting IL-8..

Medienart:

Artikel

Erscheinungsjahr:

2015

Erschienen:

2015

Enthalten in:

Zur Gesamtaufnahme - volume:2015

Enthalten in:

Mediators of inflammation - 2015(2015)

Sprache:

Englisch

Beteiligte Personen:

Hong, Zhongsi [VerfasserIn]
Hong, Haiyu [Sonstige Person]
Liu, Jian [Sonstige Person]
Zheng, Xiaobin [Sonstige Person]
Huang, Mingxing [Sonstige Person]
Li, Chunna [Sonstige Person]
Xia, Jinyu [Sonstige Person]

Links:

Volltext
www.ncbi.nlm.nih.gov
search.proquest.com
www.pubmedcentral.nih.gov
doaj.org

Themen:

Chemokines
Cytokines
Cytomegalovirus
DNA methylation
Deoxyribonucleic acid--DNA
Epigenetics
Gene expression
Health care
Hepatitis
Hospitals
Infections
Infectious diseases
Inflammation
Liver cancer
Medical prognosis
Medicine
Pathogenesis
Pathology
Proteins
RB1-214
Studies
Viral infections

doi:

10.1155/2015/629862

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC1959349503